{
    "Trade/Device Name(s)": [
        "Optilite IgM CSF Kit"
    ],
    "Submitter Information": "The Binding Site Group Ltd.",
    "510(k) Number": "K190686",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120750"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFN"
    ],
    "Summary Letter Date": "May 28, 2019",
    "Summary Letter Received Date": "March 18, 2019",
    "Submission Date": "March 8, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgM"
    ],
    "Specimen Type(s)": [
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Binding Site Optilite turbidimetric analyser"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetry",
        "Turbidimetric assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Calibrator",
        "Control",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for Optilite IgM CSF Kit, a quantitative immunoturbidimetric assay for IgM measurement in cerebrospinal fluid using the Optilite analyser",
    "Indications for Use Summary": "Quantitative in vitro measurement of IgM in cerebrospinal fluid samples using the Optilite analyser; prescription use only",
    "fda_folder": "Immunology"
}